Success Metrics

Clinical Success Rate
100.0%

Based on 6 completed trials

Completion Rate
100%(6/6)
Active Trials
2(18%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
5
45%
Ph phase_4
1
9%
Ph phase_3
1
9%

Phase Distribution

0

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution7 total trials
Phase 3Large-scale testing
1(14.3%)
Phase 4Post-market surveillance
1(14.3%)
N/ANon-phased studies
5(71.4%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

85.7%

6 of 7 finished

Non-Completion Rate

14.3%

1 ended early

Currently Active

2

trials recruiting

Total Trials

11

all time

Status Distribution
Active(3)
Completed(6)
Terminated(1)
Other(1)

Detailed Status

Completed6
Recruiting2
Withdrawn1
unknown1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
2
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 31 (14.3%)
Phase 41 (14.3%)
N/A5 (71.4%)

Trials by Status

withdrawn19%
recruiting218%
completed655%
unknown19%
not_yet_recruiting19%

Recent Activity

Clinical Trials (11)

Drug Details

Intervention Type
OTHER
Total Trials
11